“When it comes to consistent profitability, long-term growth, large competitive moats, and innovation, medical device companies can provide better returns in the long run” compared to biotech stocks, advises the author of today’s article. He proceeds to highlight three medical device stocks which, while not having generated the massive returns some biotech stocks have this year, have handily beaten the NASDAQ Biotechnology Index over the last five years – and which have upcoming catalysts for growth. For these three medical device stocks, CLICK HERE.
How These 3 Medical Device Stocks Beat Biotech
Tags:Biotech SectorBiotech StocksCompetitiveInvestinginvestorLong-Term GrowthMedical Device InvestmentsMedical Device StocksNASDAQ Biotechnology IndexProfitabilityStock MarketStrong Returns